文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

有创血压监测不改善脓毒症危重患者生存

Invasive blood pressure monitoring does not improve survival in septic critically ill patients.
PubMed 文献 · Am J Emerg Med · 2025-04-26
一句话结论多中心病例对照研究显示,脓毒症休克患者使用动脉导管有创血压监测未改善住院生存,反而与ICU住院时间延长、采血增多和输血需求增加相关。

该多中心病例对照研究纳入2021年1月至2023年12月ICU脓毒症休克患者,按SOFA评分、机械通气状态及年龄、种族、性别倾向评分1:1匹配,比较行动脉置管有创血压监测(病例组)与未置管(对照组)的结局。326例匹配患者中,住院死亡率无差异(41% vs 38%,p=0.43),但病例组ICU住院时间更长(中位5.6 vs 3.7天,p<0.01)、每日采血次数更多(中位9 vs 7,p=0.046)、最低血红蛋白更低(中位7.0 vs 7.8 g/dL,p<0.01)、红细胞输注量更多(中位2.2 vs 1.5单位,p=0.03)。作者认为需重新评估该人群常规使用动脉导管的做法。

要点

  • 匹配后326例脓毒症休克患者中,有创血压监测组与对照组住院死亡率无差异(41% vs 38%,p=0.43)。
  • 有创血压监测组ICU住院时间更长(中位5.6 vs 3.7天,p<0.01)。
  • 有创血压监测组每日采血次数更多(中位9 vs 7,p=0.046)、最低血红蛋白更低(中位7.0 vs 7.8 g/dL,p<0.01)。
  • 有创血压监测组红细胞输注量更多(中位2.2 vs 1.5单位,p=0.03)。
  • 血管活性药停用时间两组无显著差异(28.6 vs 26.5小时,p=0.82)。

适用人群与场景

  • 2021年1月至2023年12月多中心ICU脓毒症休克患者,共739例符合条件,匹配后326例纳入分析。
  • 病例组为接受动脉置管行有创血压监测者,对照组为未行动脉置管者。
  • 匹配基于SOFA评分精确匹配、机械通气状态及年龄、种族、性别倾向评分,1:1匹配。

研究设计与关键结果

  • 多中心病例对照研究,739例符合条件,326例匹配;平均年龄67±14岁,57%为男性。
  • 主要终点:住院死亡率病例组41% vs 对照组38%,p=0.43,无显著差异。
  • ICU住院时间:病例组中位5.6天 vs 对照组中位3.7天,p<0.01。
  • 血管活性药停用时间:病例组28.6小时 vs 对照组26.5小时,p=0.82,无显著差异。
  • 每日采血次数:病例组中位9次 vs 对照组中位7次,p=0.046。
  • 最低血红蛋白:病例组中位7.0 g/dL vs 对照组中位7.8 g/dL,p<0.01。
  • 红细胞输注量:病例组中位2.2单位 vs 对照组中位1.5单位,p=0.03。

证据类型、等级与局限

  • 证据类型:多中心病例对照研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,这些发现提示需要重新评估脓毒症休克危重患者中常规使用动脉导管的做法。
  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Invasive blood pressure (BP) monitoring with arterial catheters is commonly used in the management of septic shock, however its impact on recovery remains unclear. We aimed to determine whether invasive BP monitoring improves survival, impacts length of stay (LOS) or accelerates shock resolution.

METHODS: We conducted a multicenter case-control study of ICU patients with septic shock from January 2021 to December 2023. Cases received arterial lines for invasive BP monitoring; controls did not. Patients were matched 1: 1 based on exact Sequential Organ Failure Assessment (SOFA) score, mechanical ventilation status, and propensity scores using age, race, and sex. Primary outcomes were all-cause inpatient mortality and ICU LOS.

RESULTS: Among 739 eligible patients, 326 were matched. The mean age was 67 ± 14 years, and 57 % were male. Inpatient mortality was similar between cases and controls (41 % vs. 38 %, p = 0.43). Patients with arterial lines had longer ICU LOS (median 5.6 vs. 3.7 days, p < 0.01). Time to vasopressor discontinuation (28.6 vs. 26.5 h, p = 0.82) did not differ significantly. Patients with arterial lines had more daily blood draws (median 9 vs. 7, p = 0.046), lower nadir hemoglobin levels (median 7.0 vs. 7.8 g/dL, p < 0.01), and received more red blood cell transfusions (median 2.2 vs. 1.5 units, p = 0.03).

CONCLUSION: Invasive BP monitoring with arterial catheters did not improve survival in critically ill patients with septic shock. It was associated with longer lengths of stay, increased blood sampling, and higher transfusion requirements. These findings suggest the need to reassess the routine use of arterial lines in this population.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Sonti R, Fong A, Hummel E, et al. Invasive blood pressure monitoring does not improve survival in septic critically ill patients. Am J Emerg Med. 2025. PMID: 40311284. doi:10.1016/j.ajem.2025.04.060

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。